Company intelligence / Profile preview

Redmile Capital Offshore II Master Fund

George Town, Cayman Islands

Ownership: Private
Development stage: Other

Overview

Redmile Capital Offshore II Master Fund is a hedge fund vehicle managed by Redmile Group, an asset management group highly focused on investing in life sciences, biotech, pharmaceutical, and healthcare companies, including many at late-stage clinical or commercial phases, but does not itself develop drugs or have a clinical pipeline[1][2][13][14].

Industry: Investors

Beyond the preview

Go deeper on Redmile Capital Offshore II Master Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redmile Capital Offshore II Master Fund.

Explore the full profile